AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Can AI help in Drug Development ?
This is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by Analytics Vidhya.
Lot of analytics companies from silicon valley to budding startups are targeting to solve the problem of drug discovery to suggesting prescriptions. But would you really trust a cancer medicine suggested by a software program?
AI today is at a level of doing lower cognitive tasks such as aggregating numbers, finding patterns, suggesting correlations rather than understanding human level intelligence of thoughts, implications or emotions. That is why it should be used to solve the time-consuming and mundane problems leaving the quick and theoretically complex decisions to the judgement of the experts such as doctors, making it win-win for everyone.
Here, Gaurav would talk about three AI technologies Innoplexus has developed to cut down drug development time at all stages and how should one pursue the field to facilitate traditional institutions for patient care.
Evolutionary learning based Incremental crawling
Computer vision based information comprehension
Ontology-based life sciences language processing
This video originally published on youtube channel of Analytics Vidhya.
Featured News
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience.Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trialsBOSTON and DURHAM, N.C. and ESCHBORN, Germany,…
New app for cancer patients
Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…
Innoplexus wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary…
AI CTP engine estimated failure for Biogen’s aducanumab
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years…
Innoplexus launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be…